BioCentury
ARTICLE | Financial News

Antibe Therapeutics financial update

September 2, 2013 7:00 AM UTC

Antibe raised C$269,800 ($261,333) through the sale of 490,545 shares at C$0.55 in the third tranche of an IPO, bringing the total raised in the offering to C$3 million ($2.9 million). The company rai...